Attached files
file | filename |
---|---|
EX-32.2 - BVX_EXHIBIT 32.2_2017 - Apyx Medical Corp | a2017bvx10-kexhibit322.htm |
EX-32.2 - BVX_EXHIBIT 32.2_2017 - Apyx Medical Corp | a2017bvx10-kexhibit321.htm |
EX-31.2 - BVX_EXHIBIT 31.2_2017 - Apyx Medical Corp | a2017bvx10-kexhibit312.htm |
EX-31.1 - BVX_EXHIBIT 31.1_2017 - Apyx Medical Corp | a2017bvx10-kexhibit311.htm |
EX-21.1 - BVX_EXHIBIT 21.1_2017 - Apyx Medical Corp | a2017bvx10-kexhibit211.htm |
EX-10.17 - BVX_EXHIBIT 10.17_2017 - Apyx Medical Corp | a2017bvx10-kexhibit1017.htm |
EX-10.16 - BVX_EXHIBIT 10.16_2017 - Apyx Medical Corp | a2017bvx10-kexhibit1016.htm |
10-K - BVX_10-K_2017 - Apyx Medical Corp | a2017bvx10-k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED
CERTIFIED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
Bovie Medical Corporation
Clearwater, Florida
We hereby consent to the incorporation by reference in Registration Statement Numbers 333‑195624, 333‑207206 and 333-222657 on Form S‑8 and Registration Statement Numbers 333‑200986 and 333‑203422 on Form S‑3 of Bovie Medical Corporation, of our report dated March 13, 2018 on the consolidated financial statements of Bovie Medical Corporation appearing in this Annual Report on Form 10‑K.
March 13, 2018
Tampa, Florida